Walking patients treated for disabling spasticity

Objective Analysis of the management of walking adult patients with disabling spasticity in Algeria. Method In 2014 a multicenter survey has been conducted through 7 PRM centers in north Algeria; 450 adult patients treated for disabling spasticity have been identified. We report a post-hoc subgroup analysis of 259 walking patients. Results n  = 259. Mean age = 46.2 years. The most frequent etiology was post stroke hemiplegia. The patient's grievance was function (65.63%) and comfort (57.91%). The treatments received were physiotherapy (81.85%) botulinum toxin injections (67.18%)and oral medication (40.92%). Botulinum toxin therapy targeted the soleus, the gastrocnemius and the adductor muscles. Discussion The identified population is young, the botulinum toxin therapy has been used in 2/3 of the patients but the targeted muscles were not consistent with the literature. This analysis of our practice will let us improve and unify our management of spasticty.